These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 17655983)

  • 1. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.
    Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ
    Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera.
    Henckaerts I; Goldblatt D; Ashton L; Poolman J
    Clin Vaccine Immunol; 2006 Mar; 13(3):356-60. PubMed ID: 16522777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay for quantitative determination of capsular polysaccharide production in Streptococcus pneumoniae clinical isolates.
    Cruz-Leal Y; Menéndez T; Coizeau E; Espinosa RR; Canaan L; Blanco F; Carmenate T; Chang J; Quiñones D; Tamargo I; Cremata J; Verez-Bencomo V; Guillén G
    Biotechnol Appl Biochem; 2006 May; 44(Pt 2):101-8. PubMed ID: 16420190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine.
    Nguyen JT; Myers N; Palaia J; Georgopoulos A; Rubins JB; Janoff EN
    Transl Res; 2007 Sep; 150(3):172-9. PubMed ID: 17761370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
    Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
    Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
    Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P
    Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serotype-specific pneumococcal IgG measurement using two different polysaccharides from ATCC and SSI Diagnostica.
    Slotved HC; Kantsø B; Kerrn MB; Skovsted IC; Jørgensen CS
    Vaccine; 2011 Sep; 29(38):6650-5. PubMed ID: 21742004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full assignment of the 1H and 13C spectra and revision of the O-acetylation site of the capsular polysaccharide of Streptococcus pneumoniae Type 33F, a component of the current pneumococcal polysaccharide vaccine.
    Lemercinier X; Jones C
    Carbohydr Res; 2006 Jan; 341(1):68-74. PubMed ID: 16297895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing an ELISA using serotype-specific antigens from selected pneumococcal strains of own selection.
    Slotved HC; Jacobsen JN; Møller HK; Krogfelt KA
    Vaccine; 2007 Mar; 25(13):2513-7. PubMed ID: 17007972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection induced by pneumococcal surface protein A (PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharide.
    Csordas FC; Perciani CT; Darrieux M; Gonçalves VM; Cabrera-Crespo J; Takagi M; Sbrogio-Almeida ME; Leite LC; Tanizaki MM
    Vaccine; 2008 Jun; 26(23):2925-9. PubMed ID: 18440673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.
    Poolman J; Kriz P; Feron C; Di-Paolo E; Henckaerts I; Miseur A; Wauters D; Prymula R; Schuerman L
    Vaccine; 2009 May; 27(24):3213-22. PubMed ID: 19446194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.
    Concepcion NF; Frasch CE
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):266-72. PubMed ID: 11238206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full NMR assignment and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 15B.
    Jones C; Lemercinier X
    Carbohydr Res; 2005 Feb; 340(3):403-9. PubMed ID: 15680595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic epitope, gene, and immunity involved in pneumococcal glycoconjugate.
    Lee CJ; Wang TR; Tai SS
    Crit Rev Microbiol; 1997; 23(2):121-42. PubMed ID: 9226111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.
    Navarro D; Escribano A; Cebrián L; Gimeno C; García-Maset L; García-de-Lomas J;
    Clin Vaccine Immunol; 2006 Jun; 13(6):665-70. PubMed ID: 16760325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA.
    Ludolfs D; Reinholz M; Schmitz H
    J Clin Virol; 2009 Jun; 45(2):125-8. PubMed ID: 19409841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.